Shanghai is recognized for advanced CAR T-cell therapy programs supported by strong specialist education, international collaboration, and high case volumes in hematologic oncology. Many hospitals follow structured patient evaluation and planning workflows that include disease profiling, review of prior treatments, and safety screening before therapy is approved. These steps are essential for identifying patients who may benefit while reducing avoidable risks associated with immune based treatments.
The cost of CAR T-cell therapy in Shanghai typically ranges between USD 130,000 and USD 350,000. Final costs can vary depending on the CAR T product used, complexity of the cancer, length of hospital stay, and level of intensive monitoring required. Recovery is often described using milestone based patterns. The first week usually involves close inpatient observation, the first month focuses on immune recovery and side effect management, and patients gradually return to regular routines over the following months. Potential risks include cytokine release syndrome and neurologic effects, which require experienced teams and strict safety protocols. Suitability for this treatment depends on individual health status, so each patient needs a personalized evaluation by a qualified doctor.
This information is for educational purposes and does not replace an in person consultation with a qualified specialist.
Shanghai has a strong concentration of CAR T-cell therapy specialists working in accredited hospitals with experience treating international and local patients. Doctors in the city often combine clinical care with research leadership and emphasize clear communication, careful safety checks, and coordinated follow up. Many hold international certifications and have trained across multiple healthcare systems.
Dr. Vicky Lee, MD, PhD is an internationally trained hematologist and oncologist based in Shanghai. She serves as Director of the Jiahui International Cancer Center and Chief of Medical Oncology at Jiahui International Hospital. With more than 30 years of experience, she leads CAR T therapy programs with a strong focus on patient selection, treatment planning, and management of complex hematologic malignancies.
Dr. Siguo Hao, MD, PhD is a senior hematology consultant at Jiahui International Hospital and Academic Leader of the Department of Hematology at Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine. With nearly four decades of experience, he specializes in leukemia and lymphoma and has played a key role in developing CAR T-cell therapy for high risk cases.
Dr. Linli Xuan, MD is Chief of Medical Oncology at Jiahui International Cancer Center. She is board certified in internal medicine, medical oncology, and hematology and integrates CAR T therapy into personalized treatment plans for patients with lymphoma and multiple myeloma, emphasizing long term follow up and recovery monitoring.
Best Clinic Abroad supports patients who want safe access to experienced CAR T-cell therapy doctors in Shanghai. The team helps organize consultations, clarify treatment options, and coordinate logistics around each medical stay.
➤ Virtual consultation support - Arrange remote review of medical records and prior treatment history before travel.
➤ Transparent cost guidance - Request indicative price ranges and explanations of factors that influence overall treatment costs.
Patients who are considering CAR T-cell therapy in Shanghai can share their medical reports with Best Clinic Abroad to receive coordinated support and a clear starting point for treatment planning.
Question: How do doctors decide whether CAR T-cell therapy is appropriate
Answer: Doctors review cancer type, prior treatments, overall health, and safety screening results. Not every patient is a candidate, so specialist evaluation is required.
Question: What kind of follow up care is needed after CAR T-cell therapy
Answer: Follow up usually includes regular blood tests, immune monitoring, and clinic visits to watch for delayed side effects and support recovery over time.